← Evidence map

ArticleScientific reports2022

Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern.

Amanda J Griffin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2022

this papercites it

Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern. | OpenQuestion